Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SOLOSEC 2 GM GRANULE PACKET

secnidazole
$283.1540per EA

Strength

2 g/4.8g

Manufacturer

Evofem Inc.

NDC

69751040001

Classification

Brand

Dosage Form

GRANULE

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

SECNIDAZOLE

Approval Type

New Drug (NDA)

FDA Application

NDA209363

On Market Since

5/31/2018

Pharmacological Classes

Nitroimidazole Antimicrobial
Nitroimidazoles

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+4.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

+4.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

VANDAZOLE VAGINAL 0.75% GEL
Brand
00245086070•Upsher-Smith Laboratories LLC
$0.3451
per GM
PYLERA 140-125-125 MG CAPSULE
Brand
61269038012•H2-Pharma LLC
$2.4283
per EA
LIKMEZ 500 MG/5 ML SUSPENSION
Brand
71656006675•Saptalis Pharmaceuticals LLC
$2.6042
per ML
LIKMEZ 500 MG/5 ML SUSPENSION
Brand
81033006620•Kesin Pharma Corporation
$2.6093
per ML
LIKMEZ 500 MG/5 ML SUSPENSION
Brand
71656006620•Saptalis Pharmaceuticals LLC
$2.6175
per ML
METROGEL TOPICAL 1% GEL
Brand
00299382060•Galderma Laboratories, L.P.
$6.0483
per GM
TINDAMAX 500 MG TABLET
Brand
00178850020•Mission Pharmacal Company
$13.0140
per EA
TINDAMAX 500 MG TABLET
Brand
00178850060•Mission Pharmacal Company
$13.0140
per EA
NORITATE 1% CREAM
Brand
00187520260•Bausch Health US LLC
$31.2696
per GM
NUVESSA VAGINAL 1.3% GEL
Brand
00642746605•Exeltis USA, Inc.
$43.0916
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy